Promimic

Promimic is developing Hydroxyapatite (HA) as a coating for implanted devices. Promimic is the first company to develop methods for coating implants using ultrathin layers of HA. The Company is focusing on licensing the Product to implant companies worldwide.
Promimic has developed a state-of-the-art nanotechnology that mimics nature, making it possible to create a unique bioactive surface on any implant.

CEO

Magnus Larsson
Sub segment
Medical Device
Location
Mölndal, Sweden and Texas, USA

Related companies

Rosetta Capital
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.